EMRA Rep to ACGME Review Committee for Emergency Medicine Nomination Form

Selection Timeline

EMRA Nominee Submission Deadline: September 16
Two EMRA-Endorsed Candidates Selected by September 25
ACGME will notify the selected individual in February, 2023
The new resident member’s term will begin July 1, 2027, and ending June 30, 2029.
March 2027 - June 30, 2027 New RC-EM rep will shadow current RC-EM Rep

Each submitted nomination must include:

1. Two letters of recommendation
     a. Letter of support from the nominee’s program director. This letter must include an attestation that he or she will ensure that the resident will have sufficient time to participate in activities of the Review Committee and the ACGME as required.
     b. Letter of endorsement from a professional medical society of membership or other person/group - EMRA will supply this for the nominees.
2. Resident CV
3. Completed Nomination Form (Download below)

Resident-Nominee-Form-2022.docdoc 64 KB

Application Submissions are currently closed.

Related Content

Jun 24, 2020

Chronic Pain & Substance Use Disorder

Pain is one of the most prevalent, yet misunderstood, symptoms in emergency medicine. In this guide, the top pain management and palliative care authorities in the field succinctly and clearly present options for effective analgesia. Find opioid alternatives, tips for specific conditions, and more.

Jun 24, 2020

Vaso-Occlusive Pain

Pain is one of the most prevalent, yet misunderstood, symptoms in emergency medicine. In this guide, the top pain management and palliative care authorities in the field succinctly and clearly present options for effective analgesia. Find opioid alternatives, tips for specific conditions, and more.

Jun 24, 2020

Pain in Pregnancy

Pain is one of the most prevalent, yet misunderstood, symptoms in emergency medicine. In this guide, the top pain management and palliative care authorities in the field succinctly and clearly present options for effective analgesia. Find opioid alternatives, tips for specific conditions, and more.